Skip to main content

Table 1 Information for the SNPs genotyped in this study

From: Effects of FGFR gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-docetaxel-based chemotherapy in breast cancer patients

Gene Ref SNP ID Alleles MAF Primer sequences
FGFR1 rs2288696 C/T 0.14 5’-GGTGCCCTATCTGCTCTG-3′,
5’-CTTGGTGGGATGGAAACT-3’
FGFR2 rs2981582 C/T 0.40 5’-TCTGTCATCAGTAGGGAATA-3′,
5’-ATCACCAAGAGGCAGTTC-3’
  rs1219648 A/G 0.41 5’-ACATCCCTTGTTCTCGTT-3′,
5’-ATTGCCTTGGCTATTCAG-3’
  rs2420946 T/C 0.44 5’-TTTGGTGGAAGAGTCAGA-3′,
5’-GTCCCAGAGGATTTGTTT-3’
  rs2981579 T/C 0.49 5’-TGTGACTCCCTTCATCGT-3′,
5’-TGGTCTATTTCTCAATCCCTA-3’
  rs2981578 G/A 0.37 5’-CTGCTTTGGAGGATTGTGA-3′,
5’-GAGACTGGGAAACAGATGGT-3’
FGFR3 rs743682 G/A 0.17 5’-TACAAAGACCTCGTGAAATGG-3′, 5’-CAAATCCAGACTCGCTTCC-3’
FGFR4 rs1966265 G/A 0.23 5’-GCCGCCTTGTCAGTTGTG-3′,
5’-TCCTGGTGCCCACTCTTCC-3’
  1. SNP single nucleotide polymorphism, MAF minor allele frequency